• OPEN AN ACCOUNT
A+| A| A-|
Indian Indices
Sensex
77,477.35 -231.17
( -0.30%)
Global Indices
Nasdaq
51,860.73 -306.69
(-0.59%)
Dow Jones
7,464.20 -14.49
(-0.19%)
Hang Seng
63,887.74 -2,947.80
(-4.41%)
Nikkei 225
10,542.79 -57.58
(-0.54%)
Forex
USD-INR
96.42 0.06
(0.07%)
EUR-INR
110.27 -0.10
(-0.09%)
GBP-INR
129.65 -0.46
(-0.35%)
JPY-INR
0.59 0.00
(-0.05%)

EQUITY - MARKET SCREENER

Eiko Lifesciences Ltd
Industry :  Chemicals
BSE Code
ISIN Demat
Book Value()
540204
INE666Q01016
47.0490317
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
N.A
19.66
70.52
EPS(TTM)
Face Value()
Div & Yield %
2.5
10
0
 

SRF consolidated net profit rises 10.64% in the March 2026 quarter
May 05,2026
Net profit of SRF rose 10.64% to Rs 582.02 crore in the quarter ended March 2026 as against Rs 526.06 crore during the previous quarter ended March 2025. Sales rose 7.51% to Rs 4531.83 crore in the quarter ended March 2026 as against Rs 4215.17 crore during the previous quarter ended March 2025.

For the full year,net profit rose 46.72% to Rs 1835.18 crore in the year ended March 2026 as against Rs 1250.78 crore during the previous year ended March 2025. Sales rose 7.37% to Rs 15416.37 crore in the year ended March 2026 as against Rs 14358.15 crore during the previous year ended March 2025.

ParticularsQuarter EndedYear Ended
Mar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var.
Sales4531.834215.17 8 15416.3714358.15 7
OPM %22.6322.71 -22.1218.93 -
PBDT988.62902.51 10 3238.662475.20 31
PBT768.81707.36 9 2386.591703.70 40
NP582.02526.06 11 1835.181250.78 47